Extraction schema:
{"type": "object", "title": "Vanguard Schedule of Investments (real content)", "additionalProperties": false, "properties": {"fund_name": {"type": "string", "description": "Fund name as printed in the page header, e.g. 'Mega Cap Growth Index Fund'."}, "as_of_date": {"type": "string", "description": "Schedule as-of date as printed after 'As of', e.g. 'March 31, 2026'."}, "total_investments_thousands": {"type": "integer", "description": "Printed 'Total Investments' market value in $000."}, "net_assets_thousands": {"type": "integer", "description": "Printed 'Net Assets (100%)' value in $000."}, "holdings": {"type": "array", "description": "Every holding row of the Schedule of Investments, in print order.", "items": {"type": "object", "additionalProperties": false, "properties": {"security_name": {"type": "string", "description": "Security name as printed (without leading footnote markers)."}, "marks": {"type": "array", "items": {"type": "string"}, "description": "Leading superscript footnote markers, e.g. ['*'] or ['1'] or ['*','2']."}, "asset_class": {"type": ["string", "null"], "description": "Top-level class heading, e.g. 'Common Stocks'."}, "asset_class_percent": {"type": ["number", "null"], "description": "Percent of net assets printed on the class heading."}, "group": {"type": ["string", "null"], "description": "Sector/country/sub-class heading, e.g. 'Basic Materials' or 'Japan'."}, "group_percent": {"type": ["number", "null"], "description": "Percent of net assets printed on the group heading."}, "shares": {"type": ["integer", "null"], "description": "Shares held (null for face-amount rows)."}, "face_amount_thousands": {"type": ["integer", "null"], "description": "Face amount in $000 for fixed-income/repo rows (null otherwise)."}, "inline_cost_thousands": {"type": ["integer", "null"], "description": "Cost printed inline after the name as '(Cost $N)', in $000."}, "market_value_thousands": {"type": "integer", "description": "Market value in $000 (0 when printed as an em dash)."}, "source_page": {"type": ["integer", "null"], "description": "1-based PDF page where this holding row is printed."}}, "required": ["security_name", "marks", "asset_class", "asset_class_percent", "group", "group_percent", "shares", "face_amount_thousands", "inline_cost_thousands", "market_value_thousands", "source_page"]}}}, "required": ["fund_name", "as_of_date", "total_investments_thousands", "net_assets_thousands", "holdings"]}

Expected output:
{"fund_name": "Health Care Fund", "as_of_date": "January 31, 2026", "total_investments_thousands": 39150103, "net_assets_thousands": 39263818, "holdings": [{"security_name": "Argenx SE", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Belgium", "group_percent": 4.8, "shares": 1165992, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 980565, "source_page": 4}, {"security_name": "UCB SA", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Belgium", "group_percent": 4.8, "shares": 3023965, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 921479, "source_page": 4}, {"security_name": "Duality Biotherapeutics Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "China", "group_percent": 0.8, "shares": 2771377, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 117021, "source_page": 4}, {"security_name": "Jiangsu Hengrui Pharmaceuticals Co. Ltd. Class H", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "China", "group_percent": 0.8, "shares": 9939973, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 87135, "source_page": 4}, {"security_name": "Zai Lab Ltd.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "China", "group_percent": 0.8, "shares": 36431700, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 60568, "source_page": 4}, {"security_name": "Shandong Weigao Group Medical Polymer Co. Ltd. Class H", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "China", "group_percent": 0.8, "shares": 77092000, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 49360, "source_page": 4}, {"security_name": "GenFleet Therapeutics Shanghai Inc. Class H", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "China", "group_percent": 0.8, "shares": 1979400, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 7793, "source_page": 4}, {"security_name": "Genmab A/S", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Denmark", "group_percent": 2.3, "shares": 1345944, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 438489, "source_page": 4}, {"security_name": "Ascendis Pharma A/S ADR", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Denmark", "group_percent": 2.3, "shares": 1103469, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 249494, "source_page": 4}, {"security_name": "Novo Nordisk A/S Class B", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Denmark", "group_percent": 2.3, "shares": 3482834, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 206808, "source_page": 4}, {"security_name": "Otsuka Holdings Co. Ltd.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Japan", "group_percent": 5.2, "shares": 7893800, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 472589, "source_page": 4}, {"security_name": "Chugai Pharmaceutical Co. Ltd.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Japan", "group_percent": 5.2, "shares": 7912642, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 451976, "source_page": 4}, {"security_name": "Shionogi & Co. Ltd.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Japan", "group_percent": 5.2, "shares": 18640349, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 383790, "source_page": 4}, {"security_name": "Daiichi Sankyo Co. Ltd.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Japan", "group_percent": 5.2, "shares": 18367566, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 336487, "source_page": 4}, {"security_name": "Eisai Co. Ltd.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Japan", "group_percent": 5.2, "shares": 8514317, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 237374, "source_page": 4}, {"security_name": "Astellas Pharma Inc.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Japan", "group_percent": 5.2, "shares": 7516478, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 104553, "source_page": 4}, {"security_name": "M3 Inc.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Japan", "group_percent": 5.2, "shares": 5441953, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 67148, "source_page": 4}, {"security_name": "Novartis AG (Registered)", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Switzerland", "group_percent": 4.1, "shares": 3795144, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 563085, "source_page": 4}, {"security_name": "Roche Holding AG", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Switzerland", "group_percent": 4.1, "shares": 1206949, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 548848, "source_page": 4}, {"security_name": "Galderma Group AG", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "Switzerland", "group_percent": 4.1, "shares": 2623305, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 488981, "source_page": 4}, {"security_name": "AstraZeneca plc", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United Kingdom", "group_percent": 8.8, "shares": 11579638, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 2157450, "source_page": 4}, {"security_name": "GSK plc", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United Kingdom", "group_percent": 8.8, "shares": 45301487, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 1171571, "source_page": 4}, {"security_name": "Immunocore Holdings plc ADR", "marks": ["*", "1", "2"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United Kingdom", "group_percent": 8.8, "shares": 3657808, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 119062, "source_page": 4}, {"security_name": "Eli Lilly & Co.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 3696560, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 3833887, "source_page": 4}, {"security_name": "Merck & Co. Inc.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 18111825, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 1997191, "source_page": 4}, {"security_name": "UnitedHealth Group Inc.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 4772250, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 1369302, "source_page": 4}, {"security_name": "Johnson & Johnson", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 5367039, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 1219660, "source_page": 4}, {"security_name": "Edwards Lifesciences Corp.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 14972830, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 1218189, "source_page": 4}, {"security_name": "Danaher Corp.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 4836473, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 1058656, "source_page": 4}, {"security_name": "Abbott Laboratories", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 9621496, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 1051630, "source_page": 4}, {"security_name": "Intuitive Surgical Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 1944873, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 980644, "source_page": 4}, {"security_name": "Cencora Inc.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 2582479, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 927678, "source_page": 4}, {"security_name": "AbbVie Inc.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 4034908, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 899825, "source_page": 4}, {"security_name": "Medtronic plc", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 7813493, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 804477, "source_page": 4}, {"security_name": "Vertex Pharmaceuticals Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 1589663, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 746983, "source_page": 4}, {"security_name": "CVS Health Corp.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 9756578, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 727060, "source_page": 4}, {"security_name": "Elevance Health Inc.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 1879405, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 649785, "source_page": 4}, {"security_name": "Cardinal Health Inc.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 2840801, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 610431, "source_page": 4}, {"security_name": "Biogen Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 2913639, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 524135, "source_page": 4}, {"security_name": "Agilent Technologies Inc.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 3480187, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 465823, "source_page": 4}, {"security_name": "HCA Healthcare Inc.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 933410, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 455756, "source_page": 4}, {"security_name": "Alnylam Pharmaceuticals Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 1309033, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 442532, "source_page": 4}, {"security_name": "United Therapeutics Corp.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 892079, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 418822, "source_page": 4}, {"security_name": "Thermo Fisher Scientific Inc.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 702318, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 406368, "source_page": 4}, {"security_name": "Boston Scientific Corp.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 4128084, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 386100, "source_page": 4}, {"security_name": "Dexcom Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 4655231, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 340018, "source_page": 5}, {"security_name": "Ionis Pharmaceuticals Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 3803181, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 314409, "source_page": 5}, {"security_name": "Stryker Corp.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 748338, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 276556, "source_page": 5}, {"security_name": "QIAGEN NV", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 5130344, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 275346, "source_page": 5}, {"security_name": "STERIS plc", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 1012472, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 265875, "source_page": 5}, {"security_name": "Cytokinetics Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 4050667, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 255962, "source_page": 5}, {"security_name": "Bristol-Myers Squibb Co.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 4606141, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 253568, "source_page": 5}, {"security_name": "Structure Therapeutics Inc. ADR", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 2811254, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 248655, "source_page": 5}, {"security_name": "Regeneron Pharmaceuticals Inc.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 318062, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 235827, "source_page": 5}, {"security_name": "Revolution Medicines Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 2383815, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 231111, "source_page": 5}, {"security_name": "ICON plc", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 1247597, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 224879, "source_page": 5}, {"security_name": "Avantor Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 20480758, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 223650, "source_page": 5}, {"security_name": "Vaxcyte Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 3653768, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 195732, "source_page": 5}, {"security_name": "Madrigal Pharmaceuticals Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 398129, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 194808, "source_page": 5}, {"security_name": "CG oncology Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 3484986, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 181394, "source_page": 5}, {"security_name": "Kymera Therapeutics Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 2449438, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 178050, "source_page": 5}, {"security_name": "Crinetics Pharmaceuticals Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 3494255, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 174503, "source_page": 5}, {"security_name": "Bio-Techne Corp.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 2720122, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 174333, "source_page": 5}, {"security_name": "Apellis Pharmaceuticals Inc.", "marks": ["*", "1"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 7632548, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 172343, "source_page": 5}, {"security_name": "Option Care Health Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 4987675, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 169581, "source_page": 5}, {"security_name": "Incyte Corp.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 1590914, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 159203, "source_page": 5}, {"security_name": "Alignment Healthcare Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 6972595, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 157093, "source_page": 5}, {"security_name": "PTC Therapeutics Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 2038232, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 153948, "source_page": 5}, {"security_name": "Encompass Health Corp.", "marks": [], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 1600016, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 151249, "source_page": 5}, {"security_name": "Apogee Therapeutics Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 2251282, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 147481, "source_page": 5}, {"security_name": "Natera Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 636032, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 147012, "source_page": 5}, {"security_name": "Xenon Pharmaceuticals Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 3546755, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 145452, "source_page": 5}, {"security_name": "Newamsterdam Pharma Co. NV", "marks": ["*", "2"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 3953142, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 123022, "source_page": 5}, {"security_name": "Scholar Rock Holding Corp.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 2750253, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 121946, "source_page": 5}, {"security_name": "Acadia Healthcare Co. Inc.", "marks": ["*", "1"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 8815704, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 118483, "source_page": 5}, {"security_name": "Celldex Therapeutics Inc.", "marks": ["*", "1"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 4764728, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 117212, "source_page": 5}, {"security_name": "Nuvalent Inc. Class A", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 1054377, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 108485, "source_page": 5}, {"security_name": "Protagonist Therapeutics Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 1180839, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 96593, "source_page": 5}, {"security_name": "Soleno Therapeutics Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 2417215, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 93208, "source_page": 5}, {"security_name": "Arcus Biosciences Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 4124859, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 86787, "source_page": 5}, {"security_name": "Dianthus Therapeutics Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 1574735, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 84075, "source_page": 5}, {"security_name": "Inspire Medical Systems Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 1094019, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 82905, "source_page": 5}, {"security_name": "HeartFlow Inc.", "marks": ["*", "2"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 2256545, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 67403, "source_page": 5}, {"security_name": "Immunome Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 2152764, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 53001, "source_page": 5}, {"security_name": "Mineralys Therapeutics Inc.", "marks": ["*"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 1215766, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 37555, "source_page": 5}, {"security_name": "Aktis Oncology Inc.", "marks": ["*", "2"], "asset_class": "Common Stocks", "asset_class_percent": 97.5, "group": "United States", "group_percent": 71.5, "shares": 1523479, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 30850, "source_page": 5}, {"security_name": "Vanguard Market Liquidity Fund, 3.704%", "marks": ["3", "4"], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Money Market Fund", "group_percent": 0.1, "shares": 587800, "face_amount_thousands": null, "inline_cost_thousands": null, "market_value_thousands": 58780, "source_page": 5}, {"security_name": "Bank of America Securities, LLC, 3.670%, 2/2/2026 (Dated 1/30/2026, Repurchase Value $50,015, collateralized by U.S. Treasury Obligations 0.875%–4.625%, 6/30/2026–5/15/2053, with a value of $51,000)", "marks": [], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Repurchase Agreements", "group_percent": 2.1, "shares": null, "face_amount_thousands": 50000, "inline_cost_thousands": null, "market_value_thousands": 50000, "source_page": 5}, {"security_name": "Bank of America Securities, LLC, 3.670%, 2/2/2026 (Dated 1/30/2026, Repurchase Value $72,922, collateralized by U.S. Government Agency Obligations 2.000%–6.000%, 1/1/2029–7/1/2055, with a value of $74,358)", "marks": [], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Repurchase Agreements", "group_percent": 2.1, "shares": null, "face_amount_thousands": 72900, "inline_cost_thousands": null, "market_value_thousands": 72900, "source_page": 5}, {"security_name": "Bank of America Securities, LLC, 3.680%, 2/2/2026 (Dated 1/30/2026, Repurchase Value $115,035, collateralized by U.S. Government Agency Obligations 3.500%, 5/1/2052, with a value of $117,300)", "marks": [], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Repurchase Agreements", "group_percent": 2.1, "shares": null, "face_amount_thousands": 115000, "inline_cost_thousands": null, "market_value_thousands": 115000, "source_page": 5}, {"security_name": "Bank of Nova Scotia, 3.660%, 2/2/2026 (Dated 1/30/2026, Repurchase Value $94,029, collateralized by U.S. Treasury Obligations 0.000%–4.875%, 3/15/2026–5/15/2052, with a value of $95,909)", "marks": [], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Repurchase Agreements", "group_percent": 2.1, "shares": null, "face_amount_thousands": 94000, "inline_cost_thousands": null, "market_value_thousands": 94000, "source_page": 5}, {"security_name": "Barclays Capital Inc., 3.660%, 2/2/2026 (Dated 1/30/2026, Repurchase Value $53,516, collateralized by U.S. Treasury Obligations 2.875%, 4/30/2029, with a value of $54,570)", "marks": [], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Repurchase Agreements", "group_percent": 2.1, "shares": null, "face_amount_thousands": 53500, "inline_cost_thousands": null, "market_value_thousands": 53500, "source_page": 5}, {"security_name": "BNP Paribas Securities Corp., 3.650%, 2/2/2026 (Dated 1/30/2026, Repurchase Value $10,003, collateralized by U.S. Treasury Obligations 0.000%–4.250%, 4/9/2026–8/15/2054, with a value of $10,200)", "marks": [], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Repurchase Agreements", "group_percent": 2.1, "shares": null, "face_amount_thousands": 10000, "inline_cost_thousands": null, "market_value_thousands": 10000, "source_page": 5}, {"security_name": "BNP Paribas Securities Corp., 3.660%, 2/2/2026 (Dated 1/30/2026, Repurchase Value $120,337, collateralized by U.S. Treasury and Government Agency Obligations 0.625%–7.000%, 3/1/2027–2/1/2056, with a value of $122,706)", "marks": [], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Repurchase Agreements", "group_percent": 2.1, "shares": null, "face_amount_thousands": 120300, "inline_cost_thousands": null, "market_value_thousands": 120300, "source_page": 5}, {"security_name": "Credit Agricole Securities, 3.660%, 2/2/2026 (Dated 1/30/2026, Repurchase Value $8,102, collateralized by U.S. Treasury Obligations 3.000%, 2/15/2047, with a value of $8,262)", "marks": [], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Repurchase Agreements", "group_percent": 2.1, "shares": null, "face_amount_thousands": 8100, "inline_cost_thousands": null, "market_value_thousands": 8100, "source_page": 5}, {"security_name": "HSBC Bank USA, 3.670%, 2/2/2026 (Dated 1/30/2026, Repurchase Value $34,010, collateralized by U.S. Treasury Obligations 1.875%, 2/15/2051, with a value of $34,680)", "marks": [], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Repurchase Agreements", "group_percent": 2.1, "shares": null, "face_amount_thousands": 34000, "inline_cost_thousands": null, "market_value_thousands": 34000, "source_page": 5}, {"security_name": "HSBC Bank USA, 3.680%, 2/2/2026 (Dated 1/30/2026, Repurchase Value $15,505, collateralized by U.S. Government Agency Obligations 2.000%–6.500%, 1/1/2030–1/1/2055, with a value of $15,810)", "marks": [], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Repurchase Agreements", "group_percent": 2.1, "shares": null, "face_amount_thousands": 15500, "inline_cost_thousands": null, "market_value_thousands": 15500, "source_page": 6}, {"security_name": "JP Morgan Securities, LLC, 3.660%, 2/2/2026 (Dated 1/30/2026, Repurchase Value $70,021, collateralized by U.S. Treasury Obligations 0.000%, 7/30/2026, with a value of $71,400)", "marks": [], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Repurchase Agreements", "group_percent": 2.1, "shares": null, "face_amount_thousands": 70000, "inline_cost_thousands": null, "market_value_thousands": 70000, "source_page": 6}, {"security_name": "Natixis SA, 3.660%, 2/2/2026 (Dated 1/30/2026, Repurchase Value $71,122, collateralized by U.S. Treasury and Government Agency Obligations 0.375%–4.125%, 10/31/2026–2/15/2054, with a value of $72,522)", "marks": [], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Repurchase Agreements", "group_percent": 2.1, "shares": null, "face_amount_thousands": 71100, "inline_cost_thousands": null, "market_value_thousands": 71100, "source_page": 6}, {"security_name": "Nomura International plc, 3.660%, 2/2/2026 (Dated 1/30/2026, Repurchase Value $10,803, collateralized by U.S. Treasury Obligations 1.125%–4.250%, 1/15/2028–2/15/2031, with a value of $11,027)", "marks": [], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Repurchase Agreements", "group_percent": 2.1, "shares": null, "face_amount_thousands": 10800, "inline_cost_thousands": null, "market_value_thousands": 10800, "source_page": 6}, {"security_name": "Nomura International plc, 3.660%, 2/2/2026 (Dated 1/30/2026, Repurchase Value $80,024, collateralized by U.S. Treasury Obligations 3.375%–3.772%, 7/31/2027–11/30/2027, with a value of $81,600)", "marks": [], "asset_class": "Temporary Cash Investments", "asset_class_percent": 2.2, "group": "Repurchase Agreements", "group_percent": 2.1, "shares": null, "face_amount_thousands": 80000, "inline_cost_thousands": null, "market_value_thousands": 80000, "source_page": 6}]}